Annual Cash & Cash Equivalents
$183.04 M
+$96.56 M+111.65%
December 29, 2023
Summary
- As of February 7, 2025, STAA annual cash & cash equivalents is $183.04 million, with the most recent change of +$96.56 million (+111.65%) on December 29, 2023.
- During the last 3 years, STAA annual cash & cash equivalents has risen by +$30.59 million (+20.06%).
- STAA annual cash & cash equivalents is now -8.35% below its all-time high of $199.71 million, reached on December 31, 2021.
Performance
STAA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$164.00 M
-$28.77 M-14.93%
September 27, 2024
Summary
- As of February 7, 2025, STAA quarterly cash and cash equivalents is $164.00 million, with the most recent change of -$28.77 million (-14.93%) on September 27, 2024.
- Over the past year, STAA quarterly cash and cash equivalents has dropped by -$60.02 million (-26.79%).
- STAA quarterly cash and cash equivalents is now -26.79% below its all-time high of $224.02 million, reached on March 29, 2024.
Performance
STAA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STAA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +111.7% | -26.8% |
| 3 y3 years | +20.1% | +89.6% |
| 5 y5 years | +76.2% | +89.6% |
STAA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | +111.7% | -26.8% | +89.6% |
| 5 y | 5-year | -8.3% | +111.7% | -26.8% | +89.6% |
| alltime | all time | -8.3% | >+9999.0% | -26.8% | >+9999.0% |
STAAR Surgical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $164.00 M(-14.9%) |
| Jun 2024 | - | $192.78 M(-13.9%) |
| Mar 2024 | - | $224.02 M(+22.4%) |
| Dec 2023 | $183.04 M(+111.7%) | $183.04 M(+43.6%) |
| Sep 2023 | - | $127.43 M(+34.6%) |
| Jun 2023 | - | $94.69 M(+5.3%) |
| Mar 2023 | - | $89.97 M(+4.0%) |
| Dec 2022 | $86.48 M(-56.7%) | $86.48 M(-33.1%) |
| Sep 2022 | - | $129.24 M(-36.2%) |
| Jun 2022 | - | $202.49 M(+4.9%) |
| Mar 2022 | - | $193.07 M(-3.3%) |
| Dec 2021 | $199.71 M(+31.0%) | $199.71 M(+1.8%) |
| Sep 2021 | - | $196.25 M(+13.4%) |
| Jun 2021 | - | $173.08 M(+6.6%) |
| Mar 2021 | - | $162.34 M(+6.5%) |
| Dec 2020 | $152.45 M(+27.1%) | $152.45 M(+18.8%) |
| Sep 2020 | - | $128.34 M(+10.3%) |
| Jun 2020 | - | $116.31 M(+4.9%) |
| Mar 2020 | - | $110.85 M(-7.6%) |
| Dec 2019 | $119.97 M(+15.5%) | $119.97 M(+6.8%) |
| Sep 2019 | - | $112.33 M(+8.8%) |
| Jun 2019 | - | $103.25 M(+1.1%) |
| Mar 2019 | - | $102.11 M(-1.7%) |
| Dec 2018 | $103.88 M(+460.9%) | $103.88 M(+1.6%) |
| Sep 2018 | - | $102.19 M(+381.0%) |
| Jun 2018 | - | $21.25 M(+2.3%) |
| Mar 2018 | - | $20.77 M(+12.2%) |
| Dec 2017 | $18.52 M(+32.3%) | $18.52 M(+14.8%) |
| Sep 2017 | - | $16.13 M(+20.1%) |
| Jun 2017 | - | $13.44 M(-0.5%) |
| Mar 2017 | - | $13.50 M(-3.6%) |
| Dec 2016 | $14.00 M(+4.5%) | $14.00 M(-2.0%) |
| Sep 2016 | - | $14.28 M(+12.6%) |
| Jun 2016 | - | $12.69 M(+41.5%) |
| Mar 2016 | - | $8.97 M(-33.1%) |
| Dec 2015 | $13.40 M(+3.0%) | $13.40 M(-16.7%) |
| Sep 2015 | - | $16.08 M(+4.9%) |
| Jun 2015 | - | $15.34 M(+41.9%) |
| Mar 2015 | - | $10.81 M(-16.9%) |
| Dec 2014 | $13.01 M(-43.3%) | $13.01 M(-29.1%) |
| Sep 2014 | - | $18.36 M(-4.3%) |
| Jun 2014 | - | $19.19 M(-8.9%) |
| Mar 2014 | - | $21.07 M(-8.2%) |
| Dec 2013 | $22.95 M(+5.9%) | $22.95 M(-1.7%) |
| Sep 2013 | - | $23.35 M(+18.4%) |
| Jun 2013 | - | $19.73 M(+2.5%) |
| Mar 2013 | - | $19.24 M(-11.2%) |
| Dec 2012 | $21.68 M(+30.7%) | $21.68 M(+9.7%) |
| Sep 2012 | - | $19.75 M(+12.6%) |
| Jun 2012 | - | $17.54 M(+6.7%) |
| Mar 2012 | - | $16.45 M(-0.8%) |
| Dec 2011 | $16.58 M(+76.9%) | $16.58 M(-1.0%) |
| Sep 2011 | - | $16.75 M(+28.9%) |
| Jun 2011 | - | $13.00 M(+27.3%) |
| Mar 2011 | - | $10.21 M(+8.9%) |
| Dec 2010 | $9.38 M(+48.1%) | $9.38 M(+10.5%) |
| Sep 2010 | - | $8.49 M(+7.5%) |
| Jun 2010 | - | $7.90 M(-51.5%) |
| Mar 2010 | - | $16.27 M(+157.1%) |
| Dec 2009 | $6.33 M(+26.8%) | $6.33 M(+12.2%) |
| Sep 2009 | - | $5.64 M(-1.9%) |
| Jun 2009 | - | $5.75 M(+54.6%) |
| Mar 2009 | - | $3.72 M(-25.4%) |
| Dec 2008 | $4.99 M | $4.99 M(-25.5%) |
| Sep 2008 | - | $6.70 M(-24.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2008 | - | $8.85 M(-15.9%) |
| Mar 2008 | - | $10.52 M(-3.4%) |
| Dec 2007 | $10.89 M(+40.4%) | $10.89 M(-23.3%) |
| Sep 2007 | - | $14.20 M(-11.7%) |
| Jun 2007 | - | $16.08 M(+76.8%) |
| Mar 2007 | - | $9.10 M(+17.3%) |
| Dec 2006 | $7.76 M(-39.0%) | $7.76 M(-5.3%) |
| Sep 2006 | - | $8.19 M(-1.8%) |
| Jun 2006 | - | $8.34 M(-13.7%) |
| Mar 2006 | - | $9.66 M(-24.0%) |
| Dec 2005 | $12.71 M(+203.5%) | $12.71 M(-15.6%) |
| Sep 2005 | - | $15.05 M(+446.0%) |
| Jun 2005 | - | $2.76 M(-18.9%) |
| Mar 2005 | - | $3.40 M(-18.8%) |
| Dec 2004 | $4.19 M(-42.5%) | $4.19 M(-64.6%) |
| Sep 2004 | - | $11.84 M(-20.5%) |
| Jun 2004 | - | $14.90 M(+172.8%) |
| Mar 2004 | - | $5.46 M(-25.0%) |
| Dec 2003 | $7.29 M(+622.1%) | $7.29 M(-26.1%) |
| Sep 2003 | - | $9.86 M(+17.2%) |
| Jun 2003 | - | $8.41 M(+2008.8%) |
| Mar 2003 | - | $399.00 K(-60.5%) |
| Dec 2002 | $1.01 M(+18.3%) | $1.01 M(+52.2%) |
| Sep 2002 | - | $663.00 K(+7.8%) |
| Jun 2002 | - | $615.00 K(-19.5%) |
| Mar 2002 | - | $764.00 K(-10.4%) |
| Dec 2001 | $853.00 K(-86.0%) | $853.00 K(-64.9%) |
| Sep 2001 | - | $2.43 M(-38.6%) |
| Jun 2001 | - | $3.95 M(-1.8%) |
| Mar 2001 | - | $4.03 M(-33.8%) |
| Dec 2000 | $6.09 M(+84.5%) | $6.09 M(-72.0%) |
| Sep 2000 | - | $21.76 M(+410.5%) |
| Jun 2000 | - | $4.26 M(+24.8%) |
| Mar 2000 | - | $3.42 M(+3.5%) |
| Dec 1999 | $3.30 M(-29.8%) | $3.30 M(-10.8%) |
| Sep 1999 | - | $3.70 M(-7.5%) |
| Jun 1999 | - | $4.00 M(-2.4%) |
| Mar 1999 | - | $4.10 M(-12.8%) |
| Dec 1998 | $4.70 M(-25.4%) | $4.70 M(+46.9%) |
| Sep 1998 | - | $3.20 M(-13.5%) |
| Jun 1998 | - | $3.70 M(+2.8%) |
| Mar 1998 | - | $3.60 M(-42.9%) |
| Dec 1997 | $6.30 M(-3.1%) | $6.30 M(+70.3%) |
| Sep 1997 | - | $3.70 M(-7.5%) |
| Jun 1997 | - | $4.00 M(0.0%) |
| Mar 1997 | - | $4.00 M(-38.5%) |
| Dec 1996 | $6.50 M(+71.1%) | $6.50 M(-1.5%) |
| Sep 1996 | - | $6.60 M(+69.2%) |
| Jun 1996 | - | $3.90 M(-2.5%) |
| Mar 1996 | - | $4.00 M(+5.3%) |
| Dec 1995 | $3.80 M(+18.8%) | $3.80 M(-7.3%) |
| Sep 1995 | - | $4.10 M(+5.1%) |
| Jun 1995 | - | $3.90 M(+14.7%) |
| Mar 1995 | - | $3.40 M(+6.3%) |
| Dec 1994 | $3.20 M(+128.6%) | $3.20 M(+220.0%) |
| Sep 1994 | - | $1.00 M(+25.0%) |
| Jun 1994 | - | $800.00 K(0.0%) |
| Mar 1994 | - | $800.00 K(-42.9%) |
| Dec 1993 | $1.40 M(-6.7%) | $1.40 M(+600.0%) |
| Sep 1993 | - | $200.00 K(-33.3%) |
| Jun 1993 | - | $300.00 K(-80.0%) |
| Dec 1992 | $1.50 M(-34.8%) | $1.50 M(-34.8%) |
| Dec 1991 | $2.30 M(+228.6%) | $2.30 M(+187.5%) |
| Mar 1991 | - | $800.00 K(+14.3%) |
| Dec 1990 | $700.00 K(+600.0%) | $700.00 K(+600.0%) |
| Dec 1988 | $100.00 K | $100.00 K |
FAQ
- What is STAAR Surgical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for STAAR Surgical?
- What is STAAR Surgical annual cash & cash equivalents year-on-year change?
- What is STAAR Surgical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for STAAR Surgical?
- What is STAAR Surgical quarterly cash and cash equivalents year-on-year change?
What is STAAR Surgical annual cash & cash equivalents?
The current annual cash & cash equivalents of STAA is $183.04 M
What is the all time high annual cash & cash equivalents for STAAR Surgical?
STAAR Surgical all-time high annual cash & cash equivalents is $199.71 M
What is STAAR Surgical annual cash & cash equivalents year-on-year change?
Over the past year, STAA annual cash & cash equivalents has changed by +$96.56 M (+111.65%)
What is STAAR Surgical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of STAA is $164.00 M
What is the all time high quarterly cash and cash equivalents for STAAR Surgical?
STAAR Surgical all-time high quarterly cash and cash equivalents is $224.02 M
What is STAAR Surgical quarterly cash and cash equivalents year-on-year change?
Over the past year, STAA quarterly cash and cash equivalents has changed by -$60.02 M (-26.79%)